Charles Schwab
VMD icon

Charles Schwab’s Viemed Healthcare VMD Stock Holding History

Charles Schwab’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14M Buy
99,687
+8,586
+9% +$85K ﹤0.01% 2974
2026
Q1 		$839K Sell
91,101
-8,461
-8% -$70.4K ﹤0.01% 2950
2025
Q4 		$740K Sell
99,562
-4,966
-5% -$34K ﹤0.01% 3024
2025
Q3 		$710K Sell
104,528
-858
-0.8% -$5.81K ﹤0.01% 3060
2025
Q2 		$728K Buy
105,386
+5,878
+6% +$39.9K ﹤0.01% 3001
2025
Q1 		$724K Buy
99,508
+15
+0% +$118 ﹤0.01% 2953
2024
Q4 		$798K Buy
99,493
+125
+0.1% +$1.08K ﹤0.01% 2984
2024
Q3 		$728K Hold
99,368
– – ﹤0.01% 3021
2024
Q2 		$651K Buy
99,368
+8,050
+9% +$60.7K ﹤0.01% 3085
2024
Q1 		$861K Buy
91,318
+12,915
+16% +$111K ﹤0.01% 2843
2023
Q4 		$615K Buy
78,403
+369
+0.5% +$2.68K ﹤0.01% 2992
2023
Q3 		$525K Hold
78,034
– – ﹤0.01% 3021
2023
Q2 		$763K Buy
+78,034
New +$792K ﹤0.01% 2864
2022
Q2 		– Sell
-78,035
Closed -$389K – 3648
2022
Q1 		$389K Hold
78,035
– – ﹤0.01% 3153
2021
Q4 		$408K Hold
78,035
– – ﹤0.01% 3211
2021
Q3 		$434K Buy
78,035
+3,622
+5% +$23.6K ﹤0.01% 3187
2021
Q2 		$533K Sell
74,413
-553
-0.7% -$4.79K ﹤0.01% 3151
2021
Q1 		$759K Buy
74,966
+3,345
+5% +$31.5K ﹤0.01% 2942
2020
Q4 		$556K Sell
71,621
-403
-0.6% -$3.55K ﹤0.01% 2955
2020
Q3 		$623K Sell
72,024
-2,066
-3% -$20.8K ﹤0.01% 2822
2020
Q2 		$712K Buy
+74,090
New +$576K ﹤0.01% 2721

Other funds holding VMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Forager Capital Management Birmingham, Alabama $266M AUM 40% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Charles Schwab's VMD Position: Q2 2026 in Review

Charles Schwab increased its Viemed Healthcare (VMD) stake by 9.4% in Q2 2026, buying an estimated $85K and bringing the position to 99,687 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #2974.

Charles Schwab first reported a position in VMD in Q2 2020 and has held it in 21 quarters since. 166 funds tracked by Wall St. Rank hold VMD as of Q2 2026.

  • Charles Schwab held 99,687 shares of Viemed Healthcare worth $1.14M as of Q2 2026.
  • Charles Schwab bought 8,586 Viemed Healthcare shares in Q2 2026, an estimated $85K.
  • Viemed Healthcare made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2974 holding.
  • Charles Schwab first reported a position in Viemed Healthcare in Q2 2020 and has held it in 21 quarters since.
  • 166 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.